We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial (2024-25)
Product name
BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial
Sponsor name
Novartis Pharmaceuticals Australia Pty Ltd
Year Range
2024-25